Debt to Equity Ratio Chart

View Debt to Equity Ratio for USBC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 0.3274
March 31, 2026 0.0871
December 31, 2025
September 30, 2025 0.0035
June 30, 2025 -0.8093
March 31, 2025 -0.8929
December 31, 2024 -1.118
September 30, 2024 -2.357
June 30, 2024 -1.276
March 31, 2024 -3.115
December 31, 2023 2.340
September 30, 2023 0.7791
June 30, 2023 3.436
March 31, 2023 0.7248
December 31, 2022 0.3585
September 30, 2022 0.2593
June 30, 2022 0.5078
March 31, 2022 0.4432
December 31, 2021 -4.504
September 30, 2021 7.981
June 30, 2021 0.9117
March 31, 2021 0.7493
December 31, 2020 -1.152
September 30, 2020 -2.259
June 30, 2020 8.000
Date Value
March 31, 2020 -0.9139
December 31, 2019 -1.051
September 30, 2019 -1.274
June 30, 2019 -2.729
March 31, 2019 -6.038
December 31, 2018 -0.7181
September 30, 2018 -0.9205
June 30, 2018 -1.155
March 31, 2018 -0.5841
December 31, 2017 -0.4908
September 30, 2017 -0.4382
June 30, 2017 -0.3131
March 31, 2017 -0.2939
December 31, 2016 -0.3995
September 30, 2016 -0.7403
June 30, 2016 -0.6001
March 31, 2016 -0.3287
December 31, 2015 -0.257
September 30, 2015 -0.2368
June 30, 2015 -0.4033
March 31, 2015 -0.3339
December 31, 2014 -0.2417
September 30, 2014 -0.4276
June 30, 2014 -0.2661
March 31, 2014 -0.1701

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Accuray, Inc. 4.502
Micron Solutions, Inc. --
Orthofix Medical, Inc. 0.6102
ResMed, Inc. 0.1254
Rockwell Medical, Inc. 0.3971